ACIDERELI H, CEVIK O. Investigation of the effects of bicalutamide and TRAIL signaling mechanism on docetaxel resistant prostate cancer cells. J.Res.Pharm. 2022; 26(4): 980-991. http://dx.doi.org/10.29228/jrp.195